drugset / Trial / NCT01206660
Effects of Desoximetasone Spray 0.25% in Patients With Moderate to Severe Plaque Psoriasis
RandomizedParallel-groupTriple-blindTreatment
Summary
The objective of this study is to demonstrate that desoximetasone 0.25% topical spray is effective for the treatment of patients with moderate to severe plaque psoriasis.
Timeline
- Start
- 2010-08
- Primary completion
- 2010-12
- Completion
- 2011-01
Outcome
Met primary endpoint
registry analysis (superiority or other test); Desoximetasone Spray 0.25% vs Placebo; p <0.0001; t-test, 2 sided NCT01206660 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Desoximetasone | Small molecule | 0.25 % | Topical |